Nilsson I M, Kirkwood T B, Barrowcliffe T W
Thromb Haemost. 1979 Dec 21;42(4):1230-9.
The recovery and half-life of VIII:C in the plasma of severely haemophilic patients was measured by one-stage and two-stage assays after injection of two Factor VIII concentrates (Hemofil, Hyland and Fraction I-O, Kabi). Plasma volumes were measured with an Evans' Blue technique, and both concentrates and post-infusion samples were measured against the same plasma standard. There was a highly significant difference in recoveries estimated by the two assay methods. The one-stage assays gave the most consistent results, in that the average recovery was 100%, whereas the two-stage assays gave only about 80% of the value expected from in vitro assays. There was no differences in recoveries between the two concentrates. The two-stage assays gave a slightly shorter half-life than the one-stage assays, and the half-life of Hemofil was also shorter than that of Fraction I-O.
通过对两名重度血友病患者注射两种凝血因子VIII浓缩剂(海莫菲,海兰公司生产;I-O因子,卡比公司生产)后,采用一步法和两步法测定血浆中VIII:C的回收率和半衰期。用伊文思蓝技术测定血浆容量,浓缩剂和输注后样本均以同一血浆标准物进行测定。两种测定方法估算的回收率存在极显著差异。一步法测定结果最为一致,平均回收率为100%,而两步法测定结果仅为体外测定预期值的约80%。两种浓缩剂的回收率无差异。两步法测定的半衰期比一步法略短,海莫菲的半衰期也比I-O因子短。